MedPath

A randomized controlled trial of venlafaxine versus placebo for depression amongst persons with lymphoma or leukaemia

Not Applicable
Completed
Conditions
Depression amongst persons with lymphoma or leukaemia
Mental and Behavioural Disorders
Reaction to severe stress, and adjustment disorders
Registration Number
ISRCTN51232664
Lead Sponsor
Department of Health (UK)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Persons with lymphoma or leukaemia with depression as assessed using the Hamilton Rating Scale for Depression.

Exclusion Criteria

Does not meet inclusion criteria

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath